ASE TECHNOLOGY HOLDING -ADR (ASX) Stock News
NYSE:ASX - New York Stock Exchange, Inc. - US00215W1009 - ADR - Currency: USD
ASX Latest News and Analysis
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Life360 to Announce Q4 and Full Year 2024 Financial Results on February 27, 2025
Dotz Nano to Present at the Small Cap Growth Virtual Investor Conference February 6th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
Trump Says Its Time For US To 'Return' To A System That Made It Rich And Powerful As The President Proposes Tariffs On Taiwan: 'Bring Production Back To Our Country'
President Donald Trump's pledge to impose sweeping tariffs on imports from Taiwan is raising concerns across semiconductor and pharmaceutical industries, particularly affecting Taiwan Semiconductor Manufacturing Co., the world's largest contract chipmaker.
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
Baker Hughes Secures Liquefaction Equipment Order for Woodside Louisiana LNG
ASE’s Sustainability Efforts Receive International Recognition With a Ranking on the Dow Jones Sustainability Indices for the Ninth Year in a Row
Precious Metals & Critical Materials Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Precious Metals & Critical Materials Virtual Investor Conference Agenda Announced for December 10th and 11th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
American Rare Earths to Present at the Precious Metals & Critical Materials Virtual Investor Conference December 11th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Life360 Named One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500™
Attributes 278% revenue growth to continued focus and execution of key strategic growth pillars
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
Life360 Reports Record Q3 2024 Results
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
ISE Labs Investment Secures the Establishment of New Site for Semiconductor Packaging and Test in Mexico
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
– Peer-Reviewed Publication Describes How ATH434 Uniquely Targets Excess Iron –
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
ASE “Guardians of the Sea” Wins Gold at the PwC Sustainability Impact Awards
Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT Trial
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
Small Cap Growth Virtual Investor Conference Agenda Announced for October 10th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com